Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes

    In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ...

    View Details

  • S2212 SHORTER ANTHRACYCLINE-FREE CHEMO IMMUNOTHERAPY ADAPTED TO PATHOLOGICAL RESPONSE IN EARLY TRIPLE NEGATIVE BREAST CANCER (SCARLET) A RANDOMIZED PHASE III STUDY

    This study is for patients with early-stage triple-negative breast cancer (TNBC). The study team wants to compare two kinds of treatments, one with a drug ...

    View Details

  • A Phase III Randomized Double-blind Placebo-controlled Multicenter Basket Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Satralizumab in Patients with Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) or Anti-Leucine-rich-glioma-inactivated 1 (LGI-1) Encephalitis

    The purpose of this study is to assess the effects, good or bad, of satralizumab in patients with autoimmune encephalitis.

    Satralizumab is an experimental drug ...

    View Details

  • A Feasibility Study for an Observational Asian American Native Hawaiian and Pacific Islander (Asa-Nhpi) Cohort

    In this study participants will complete a survey and cognitive interview to assess survey comprehension. The purpose of this study is to refine study procedures ...

    View Details

  • A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis

    The purpose of this research study is to see how safe the study drug, EXE-346, is after 4 weeks of treatment in patients with high ...

    View Details

  • A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

    The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...

    View Details

  • EVALUATION OF FREQUENCY ALLOCATION TABLES FOR RECENTLY IMPLANTED SINGLE-SIDED DEAF COCHLEAR IMPLANT USERS

    This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ...

    View Details

  • A Phase 2 Multicenter Multinational Randomized Double-blind Placebo-controlled Study to Assess the Safety Efficacy and Pharmacokinetics of Multiple Dose Levels of ESK-001 in Adult Patients with Systemic Lupus Erythematosus

    The purpose of this study is to assess the effectiveness and safety of an investigational drug (ESK-001) in adult patients with systemic lupus erythematosus (SLE ...

    View Details